Company profile: Caprotec Bioanalytics
1.1 - Company Overview
Company description
- Provider of proprietary capture protein technology for pharmaceutical, agrochemical, and biotech industries, including Capture Compound Mass Spectrometry (CCMS) based on multifunctional small molecules (Capture Compounds) used to target, capture, and isolate, reducing the complexity of protein mixtures and samples in a targeted and directed manner.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Caprotec Bioanalytics
Biomatrica
HQ: United States
Website
- Description: Provider of biostability technologies to stabilize, process, store and ship biological samples at room temperature, preserving complex biological samples and assays based on the principles of anhydrobiosis; products include LBgard Blood Tubes for room‑temperature stabilization of blood samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomatrica company profile →
CrestOptics
HQ: Italy
Website
- Description: Provider of advanced fluorescence microscopy systems and modules, including CICERO widefield and spinning disk confocal for inverted/upright setups with wide spectral range and high resolution; X-Light V3 spinning disk confocal enabling dual-camera, high-speed, large FOV imaging; DeepSIM super-resolution module; and VisiView software for integrating and optimizing imaging protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CrestOptics company profile →
Immunophotonics
HQ: United States
Website
- Description: Provider of immunotherapy-based cancer treatments, including IP-001, a proprietary glycan polymer that stimulates immune responses against cancer and infectious diseases by acting as an antigen depot and immune activator; and an Abscopalizing Technique involving IP-001 injection with tumor ablation or radiation to induce a systemic immune response against cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunophotonics company profile →
ProteinSimple
HQ: United States
Website
- Description: Provider of protein tools and analysis solutions that help researchers resolve protein analysis problems to reveal insights into proteins and their role in disease; part of the Protein Platforms division of Bio-Techne (NASDAQ: TECH).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProteinSimple company profile →
Enza Biotech
HQ: Sweden
Website
- Description: Provider of research and development of renewable surfactants using carbohydrate-based chemistry, operating at the intersection of science and business to support the transition from a fossil-dependent to a biobased society; founded in 2012 and based at Chemical Center in Lund, Southern Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enza Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Caprotec Bioanalytics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Caprotec Bioanalytics
2.2 - Growth funds investing in similar companies to Caprotec Bioanalytics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Caprotec Bioanalytics
4.2 - Public trading comparable groups for Caprotec Bioanalytics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →